Development of genotoxic impurities guidelines and their impact on regulatory review

被引：0
|
作者：
Klenke, Elisabeth [1 ]
机构：
[1] Swissmedic, Bern, Switzerland
来源：
TOXICOLOGY LETTERS | 2013年 / 221卷
关键词：
RISK;
D O I：
10.1016/j.toxlet.2013.06.053
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [31] The position of the in vitro micronucleus test within the battery of screening for genotoxic potential determination and the regulatory guidelines
    Marzin, D
    [J]. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1997, 392 (1-2) : 175 - 181
  • [32] IMPURITIES IN ORGANIC SYNTHETIC DRUGS - A REVIEW OF REGULATORY AND TOXICOLOGICAL CONSIDERATIONS
    MAHONEY, K
    SCALES, MDC
    TUCKER, ML
    [J]. ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1993, 12 (02): : 129 - 138
  • [33] A Primer for Pharmaceutical Process Development Chemists and Analysts in Relation to Impurities Perceived to Be Mutagenic or "Genotoxic"
    Snodin, David J.
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2020, 24 (11) : 2407 - 2427
  • [34] Genotoxic Impurities in Critical Analysis of Product Development: Recent Advancements, Patents, and Current Challenges
    Swain, Suryakanta
    Jena, Bikash Ranjan
    Rao, Areti Anka
    Malothu, Narender
    Kothakota, Naga Jogayya
    Tripathy, Satya Narayan
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (04) : 385 - 395
  • [35] THE REGULATORY IMPACT ON OIL DEVELOPMENT
    BLOOM, P
    [J]. MATERIALS AND SOCIETY, 1981, 5 (01): : 11 - 16
  • [36] Genotoxic and non-genotoxic impurities in pharmaceuticals Current regulations, status and trend
    Roy, Arindam
    Nyarady, Stefan
    Matchett, Michael
    [J]. CHIMICA OGGI-CHEMISTRY TODAY, 2009, 27 (02) : xix - xxiii
  • [37] Advances on genotoxic impurities of sulfonate esters in pharmaceuticals
    Liu Xuewei
    Li Cheng
    Han Haiyun
    Zhang Wenpeng
    Chen Dongying
    [J]. CHINESE JOURNAL OF CHROMATOGRAPHY, 2018, 36 (10) : 952 - 961
  • [38] Genotoxic impurities: Safety in a Pandora's box?
    Goldfain-Blanc, Francoise
    Wattrelos, Olivier
    Lorge, Elisabeth
    Gervais, Veronique
    Gignoux, Claire
    Claude, Nancy
    [J]. TOXICOLOGY LETTERS, 2009, 189 : S272 - S272
  • [39] Genotoxic impurities in production batches of drug substances
    O'Donovan, Mike
    [J]. MUTAGENESIS, 2010, 25 (06) : 639 - 640
  • [40] Comprehensive Toxicology Risk Assessment for Genotoxic Impurities
    Bercu, Joel P.
    Callis, Courtney M.
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (05) : 938 - 938
12345